HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

NCT/Study#

N/A /

SIND-179751-BELANTAMAB-W-B

Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient W-B

DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information: